Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.98M Sell
62,078
-5,840
-9% -$684K 0.32% 60
2026
Q1
$8.17M Sell
67,918
-5,903
-8% -$681K 0.36% 47
2025
Q4
$7.77M Buy
73,821
+55,706
+308% +$5.23M 0.34% 59
2025
Q3
$1.52M Buy
18,115
+1,555
+9% +$128K 0.11% 165
2025
Q2
$1.31M Sell
16,560
-778
-4% -$61.8K 0.1% 182
2025
Q1
$1.56M Sell
17,338
-302
-2% -$28.2K 0.14% 148
2024
Q4
$1.75M Buy
+17,640
New +$1.82M 0.15% 124

Other funds holding MRK

BFC Planning, Inc.'s MRK Position: Q2 2026 in Review

BFC Planning, Inc. reduced its Merck (MRK) stake by 8.6% in Q2 2026, selling an estimated $684K and leaving 62,078 shares worth $7.98M. The position accounts for 0.32% of the portfolio, ranked #60.

BFC Planning, Inc. first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.17M in Q1 2026. 3,866 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • BFC Planning, Inc. held 62,078 shares of Merck worth $7.98M as of Q2 2026.
  • BFC Planning, Inc. sold 5,840 Merck shares in Q2 2026, an estimated $684K.
  • Merck made up 0.32% of BFC Planning, Inc.'s portfolio in Q2 2026, its #60 holding.
  • BFC Planning, Inc. first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Merck position peaked at $8.17M in Q1 2026.
  • 3,866 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.